NOLAN MANGINI SIOBHAN (Chief Financial Officer) received a stock award from NGM BIOPHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/6/2023ACC: 0001209191-23-016401
Officer· Chief Financial Officer
Since Jul 2020
+504K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
504K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+76K
Price / share
—
Trade value
—
% of position
New position
3/2/2023
0.00→76K
Total
Net shares
+76K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/2/2023 | A · Award | +76K | — | — | New position | 0.00 | 76K |
| Total | +76K | $0.00 | ||||||
Derivative Transactions2
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
228K shares
Shares
+228K
Strike price
4.36
Held after
228K
Exercisable
—
3/2/2023
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
200K shares
Shares
+200K
Strike price
4.36
Held after
200K
Exercisable
—
3/2/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock228K shares | 3/2/2023 | A · Award | +228K | 4.36 | — | 228K |
| Stock Option (Right to Buy) Direct | Common Stock200K shares | 3/2/2023 | A · Award | +200K | 4.36 | — | 200K |